OR WAIT null SECS
October 14, 2022
Alexion’s acquisition of LogicBio is designed to accelerate the company’s growth in genomic medicines.
October 12, 2022
Eli Lilly and Company will partner with Schrödinger to develop and optimize small molecule compounds.
October 10, 2022
Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.
October 06, 2022
H.I.G. Capital’s portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals.
October 02, 2022
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
September 30, 2022
Novo Nordisk will pay up to $700 million for the exclusive rights to develop and commercialize candidates from Ventus Therapeutics NLRP3 inhibitor portfolio.
September 28, 2022
Actylis combines Aceto and its 10 acquired specialists into a singular global brand.
September 20, 2022
CytoReason has announced an expanded collaboration deal with Pfizer to deliver AI for drug discovery and development.
September 19, 2022
Novo Nordisk and Microsoft are collaborating to accelerate drug discovery and development using big data and artificial intelligence.
Ensysce Biosciences and Quotient Sciences are partnering to develop and test Ensysce’s novel opioid designed to prevent abuse and overdose.